Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Beclometasone Dipropionate Suspension for Inhalation

Approval Number

国药准字HJ20130214

CompanyCHIESI FARMACEUTICI S.P.A.

Registration Date

February 14, 2023

Previous Approval Numbers

H20130214

Drug Information

Generic Name

吸入用丙酸倍氯米松混悬液

Dosage Form

吸入混悬剂

Strength

2ml：0.8mg

Drug Type

化学药品

Registration Date

February 14, 2023

Expiry Date

February 13, 2028

Company Information

Applicant Company

Company NameCHIESI FARMACEUTICI S.P.A.

Company Address

Via Palermo 26/A - 43122 Parma, Italy

Manufacturing Company

Company NameCHIESI FARMACEUTICI S.P.A.

Company Address

Via San Leonardo 96 - 43122 Parma(PR), Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

吸入用丙酸倍氯米松混悬液 - NMPA 批准文号 | MedPath